Intraperitoneal chemotherapy: Who, what, when, and how in diverse academic settings. Efficacy of lower dose of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback